BLT 0.00% 2.6¢ benitec biopharma limited

Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL, page-5

  1. 173 Posts.
    lightbulb Created with Sketch. 2
    As the BLT site states they are looking at 7 trial sites.
    I suggest the more trial sites the better chance of finding suitable candidates in a larger pool.
    Question, do they start from scratch, or will the new patients recieve the dosing of the second cohort?
    No bad news here.
    Status

    TT-034 has entered a Phase l/lla human clinical trial:
    • Benitec has two trial sites - Duke Clinical Research Centre where dosing has commenced and University of California San Diego which is recruiting.
    • An additional five trial sites are being negotiated, with two expected to be operational in early 2015.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.